Florian Muller is primarily interested in mitochondrial free radical production and its relation to aging and cancer. Dr. Muller’s team proposed a novel strategy for molecular targeted therapy in cancer, exploiting vulnerabilities exposed by passenger deleted genes (“Collateral lethality”). His group presented proof-of-principal data for one example of this strategy, where glioma cells with passen...